Leveraging Lipocalins for Drug Development

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.10, 2005-01, pp. : 3-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leveraging Population‐Based Clinical Quantitative Phenotyping for Drug Repositioning

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 7, Iss. 2, 2018-02 ,pp. : 124-129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug-Glycosidation and Drug Development

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 4, 2013-04 ,pp. : 584-596

Bentham Science Publishers

Access to resources Recommend Favorite

Leveraging Cell Cycle Analysis in Anticancer Drug Discovery to Identify Novel Plasmodial Drug Targets

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 10, Iss. 3, 2010-01 ,pp. : 165-190

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Development in Japan: Opportunities and Challenges in Drug Development

By Takahashi Kihito

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 5, 2007-01 ,pp. : 331-338

Adis International

Access to resources Recommend Favorite

Atherosclerosis imaging in drug development

By Nicholls Stephen J Kalidindi Srinivasa Moon Keon-Woong Nissen Steven E

Expert Opinion on Drug Discovery, Vol. 2, Iss. 9, 2007-09 ,pp. : 1241-1250

Informa Healthcare

Access to resources Recommend Favorite